Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 6-hydroxy-8-(1-hydroxy-2-((2-(4-methoxyphenyl)-1,1-dimethylethyl)amino)ethyl)-2h-1,4-benzoxazin-3(4h)-one
2. Bi 1744 Cl
3. Bi-1744 Cl
4. Olodaterol
5. Striverdi Respimat
1. 869477-96-3
2. Olodaterol Hcl
3. Striverdi Respimat
4. Bi 1744 Cl
5. Bi-1744-cl
6. Bi 1744 Hydrochloride
7. Bi-1744 Cl
8. Olodaterol Hydrochloride [usan]
9. Chebi:83309
10. Olodaterol (hydrochloride)
11. 65r445w3v9
12. 2h-1,4-benzoxazin-3(4h)-one, 6-hydroxy-8-((1r)-1-hydroxy-2-((2-(4-methoxyphenyl)- 1,1-dimethylethyl)amino)ethyl)-, Hydrochloride (1:1)
13. 6-hydroxy-8-((1r)-1-hydroxy-2-((2-(4-methoxyphenyl)-1,1-dimethylethyl)amino)ethyl)- 2h-1,4-benzoxazin-3(4h)-one Hydrochloride
14. Striverdi Respimat (tn)
15. 6-hydroxy-8-[(1r)-1-hydroxy-2-[[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino]ethyl]-4h-1,4-benzoxazin-3-one;hydrochloride
16. Unii-65r445w3v9
17. (r)-6-hydroxy-8-(1-hydroxy-2-((1-(4-methoxyphenyl)-2-methylpropan-2-yl)amino)ethyl)-2h-benzo[b][1,4]oxazin-3(4h)-one Hydrochloride
18. 869477-96-3 (hcl)
19. Schembl560669
20. Bi-1744 Hcl
21. Chembl2105743
22. Dtxsid901027733
23. Amy16778
24. Bcp16765
25. Ex-a2815
26. Olodaterol(bi-1744) Hydrochloride
27. Bdbm50538807
28. Hy-14301a
29. Olodaterol Hydrochloride (jan/usan)
30. Olodaterol Hydrochloride [mi]
31. S5925
32. Akos030524628
33. Olodaterol Hydrochloride [vandf]
34. Olodaterol Hydrochloride [who-dd]
35. Ac-29884
36. As-58291
37. Cs-0021887
38. Olodaterol Hydrochloride [orange Book]
39. D10020
40. A862976
41. Q27156746
42. 2h-1,4-benzoxazin-3(4h)-one, 6-hydroxy-8-[(1r)-1-hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-, Hydrochloride (1:1)
43. 6-hydroxy-8-[(1r)-1-hydroxy-2-{[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino}ethyl]-2h-1,4-benzoxazin-3(4h)-one Hydrochloride
44. N-[(2r)-2-hydroxy-2-(6-hydroxy-3-oxo-3,4-dihydro-2h-1,4-benzoxazin-8-yl)ethyl]-1-(4-methoxyphenyl)-2-methylpropan-2-aminium Chloride
Molecular Weight | 422.9 g/mol |
---|---|
Molecular Formula | C21H27ClN2O5 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 7 |
Exact Mass | 422.1608497 g/mol |
Monoisotopic Mass | 422.1608497 g/mol |
Topological Polar Surface Area | 100 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 521 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Treatment of cystic fibrosis
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
56
PharmaCompass offers a list of Olodaterol Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Olodaterol Hydrochloride manufacturer or Olodaterol Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Olodaterol Hydrochloride manufacturer or Olodaterol Hydrochloride supplier.
PharmaCompass also assists you with knowing the Olodaterol Hydrochloride API Price utilized in the formulation of products. Olodaterol Hydrochloride API Price is not always fixed or binding as the Olodaterol Hydrochloride Price is obtained through a variety of data sources. The Olodaterol Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Olodaterol HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Olodaterol HCl, including repackagers and relabelers. The FDA regulates Olodaterol HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Olodaterol HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Olodaterol HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Olodaterol HCl supplier is an individual or a company that provides Olodaterol HCl active pharmaceutical ingredient (API) or Olodaterol HCl finished formulations upon request. The Olodaterol HCl suppliers may include Olodaterol HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Olodaterol HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Olodaterol HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Olodaterol HCl active pharmaceutical ingredient (API) in detail. Different forms of Olodaterol HCl DMFs exist exist since differing nations have different regulations, such as Olodaterol HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Olodaterol HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Olodaterol HCl USDMF includes data on Olodaterol HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Olodaterol HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Olodaterol HCl suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Olodaterol HCl Drug Master File in Korea (Olodaterol HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Olodaterol HCl. The MFDS reviews the Olodaterol HCl KDMF as part of the drug registration process and uses the information provided in the Olodaterol HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Olodaterol HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Olodaterol HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Olodaterol HCl suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Olodaterol HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Olodaterol HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Olodaterol HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Olodaterol HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Olodaterol HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Olodaterol HCl suppliers with NDC on PharmaCompass.
Olodaterol HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Olodaterol HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Olodaterol HCl GMP manufacturer or Olodaterol HCl GMP API supplier for your needs.
A Olodaterol HCl CoA (Certificate of Analysis) is a formal document that attests to Olodaterol HCl's compliance with Olodaterol HCl specifications and serves as a tool for batch-level quality control.
Olodaterol HCl CoA mostly includes findings from lab analyses of a specific batch. For each Olodaterol HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Olodaterol HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Olodaterol HCl EP), Olodaterol HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Olodaterol HCl USP).